 | Up a level |
Vastesaeger, Nathan, Kutzbach, Abraham Garcia, Amital, Howard, Pavelka, Karel, Alicia Lazaro, Maria, Moots, Robert J 
ORCID: 0000-0001-7019-6211, Wollenhaupt, Juergen, Zerbini, Cristiano AF, Louw, Ingrid, Combe, Bernard et al (show 8 more authors)
(2016)
Prediction of remission and low disease activity in disease-modifying anti-rheumatic drug-refractory patients with rheumatoid arthritis treated with golimumab.
RHEUMATOLOGY, 55 (8).
pp. 1466-1476.
Bowman, Simon J, Fox, Robert, Doerner, Thomas, Mariette, Xavier, Papas, Athena, Grader-Beck, Thomas, Fisher, Benjamin A, Barcelos, Filipe, De Vita, Salvatore, Schulze-Koops, Hendrik et al (show 6 more authors)
(2022)
Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjogren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial.
LANCET, 399 (10320).
pp. 161-171.